Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMounjaro (tirzepatide) can affect menstrual cycles in some women, typically through the hormonal and metabolic shifts that follow significant weight loss rather than as a direct pharmacological effect on the reproductive system. Cycle changes — irregular timing, heavier or lighter flow, or periods returning after a long absence — are reported by women on tirzepatide, particularly in the early months of treatment. These changes are not listed as a recognised side effect in the Mounjaro prescribing information, but they are well-documented in the wider context of rapid weight loss and changing insulin sensitivity. Because Mounjaro is a prescription-only medicine requiring a clinical assessment before it can be supplied, any menstrual changes worth understanding should be part of the conversation with your prescriber from the outset.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Most women who notice menstrual changes on tirzepatide are experiencing the downstream effects of weight loss rather than the drug acting on the ovaries or uterus. Body-fat percentage, insulin levels and sex-hormone-binding globulin are tightly coupled: as weight falls and insulin sensitivity improves, the hormonal environment shifts, and the hypothalamic-pituitary-ovarian axis can respond. The result is cycles that feel different in length, heaviness or regularity.
There is a common assumption that tirzepatide must be doing something directly to reproductive hormones. In fact, the NHS tirzepatide medicines page does not list menstrual irregularity among the recognised side effects. That does not mean changes cannot happen, it means the mechanism is indirect. The same pattern appears with other significant weight-loss interventions, from bariatric surgery to low-calorie diets.
If you want to understand the broader picture of how tirzepatide works in the body, the tirzepatide overview covers the dual GIP and GLP-1 mechanism in detail. The short version: it slows gastric emptying and reduces appetite, and as adipose tissue falls, so does the hormonal noise that disrupts cycles in many women.
Practically, this means changes in the first three to four months are not unusual and often settle once weight loss stabilises. That said, if you want a fuller picture of how Mounjaro and your period interact, it is worth reading through the detail before your next prescriber check-in.
This is where the changes can be most pronounced, and for many women, most welcome. PCOS drives irregular or absent periods partly through elevated androgens and insulin resistance. Tirzepatide tackles both pathways: it reduces overall weight and markedly improves insulin sensitivity. As those two things shift, androgen levels tend to fall and the cycle can begin to regulate itself.
Women who have not had a period for months or years sometimes find one arrives unexpectedly in the early weeks of treatment. This catches some people off guard. It is not a sign that something has gone wrong; it is typically the reproductive system waking up as the metabolic environment changes. Several questions about this exact experience are among the most common ones our clinical team fields.
The corollary is important: restored ovulation means restored fertility. If you were not ovulating before and you begin to again, you can conceive. This is not theoretical. If your contraceptive plans were built around the assumption of irregular cycles or low fertility, it is worth revisiting them, and worth reading about why Mounjaro can cause periods to return in more detail.
Women who find their periods become heavier rather than more regular may simply be experiencing the adjustment that comes with a more active hormonal cycle after a period of suppression. If heavy bleeding persists beyond two or three cycles, that warrants a conversation with your GP rather than waiting for your next Mounjaro review.
This is the practical question that matters most. NHS England's guidance for women taking weight-management injections is clear: oral contraceptive pills may be absorbed less reliably during the first four weeks of tirzepatide treatment and for four weeks after every dose increase. The reason is the slowed gastric emptying that tirzepatide produces, the pill sits in the gut longer, and its absorption window shifts.
The recommended action is straightforward: add a non-oral method of contraception (condoms are the simplest) during those windows. This is specific to tirzepatide; the equivalent concern has not been demonstrated for semaglutide-based treatments. Full details are covered in the NHS England weight-management injections guidance.
Beyond the pill absorption question, Mounjaro is not recommended in pregnancy, during breastfeeding or for anyone actively trying to conceive. If your periods returning on treatment changes your family-planning picture, tell your prescriber at the next review. Many women also ask whether Mounjaro can affect periods in ways they had not anticipated, because the experience is not uniform, some find cycles arrive more reliably; others find they thin out or pause temporarily during rapid weight loss phases.
If you are on HRT rather than the pill, NHS England advises discussing whether transdermal HRT (patches or gels) might suit you better during tirzepatide treatment, for similar absorption-related reasons. Raise this with whoever manages your HRT.
Most cycle changes in the first few months of tirzepatide treatment are benign and settle. A few situations call for more than watchful waiting.
Get medical advice promptly if: bleeding is very heavy (soaking through protection in under an hour over several hours), you experience significant pelvic pain alongside cycle changes, you have a positive pregnancy test, or your periods stop entirely for more than three months and you have ruled out pregnancy. If you are wondering whether Mounjaro can stop periods altogether, that page sets out what the evidence suggests and when a stopped period needs medical attention. None of these are emergencies in themselves, but they each need assessment beyond a weight-management review.
If you are uncertain whether what you are experiencing is a normal response to weight loss or something that needs investigation, a GP is the right first port of call. Our prescribers at nume review your treatment at every stage, questions about how Mounjaro affects periods come up regularly, and they are never a trivial concern. You can also browse our FAQs for answers to common questions between consultations.
For anyone thinking about whether tirzepatide might be appropriate for their situation, an overview of weight-loss treatment options is a useful starting point before booking. When you are ready, speak to our prescribers through a free consultation, a real clinician reviews your case the same day, not software.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.